These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22220825)

  • 1. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.
    Bangalore S; Ley L
    Expert Opin Pharmacother; 2012 Feb; 13(3):345-55. PubMed ID: 22220825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens.
    Zeng F; Patel BV; Andrews L; Frech-Tamas F; Rudolph AE
    Curr Med Res Opin; 2010 Dec; 26(12):2877-87. PubMed ID: 21067459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in blood pressure control and the potential role of single-pill combination therapies.
    Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
    Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term blood pressure control: what can we do?
    Neutel JM
    Postgrad Med; 2011 Jan; 123(1):88-93. PubMed ID: 21293088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
    Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
    Greathouse MK; Weir MR
    Postgrad Med; 2012 Mar; 124(2):40-52. PubMed ID: 22437214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blocker combinations: from guidelines to clinical practice.
    Narkiewicz K
    Blood Press; 2012 Apr; 21(2):73-81. PubMed ID: 21830845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S; Roughead EE; Bartlett LE
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
    Guthrie RM
    Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing blood pressure control through the use of fixed combinations.
    Düsing R
    Vasc Health Risk Manag; 2010 May; 6():321-5. PubMed ID: 20531950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive medication changes and blood pressure goal achievement in a managed care population.
    Engel-Nitz NM; Darkow T; Lau H
    J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.